These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

835 related items for PubMed ID: 29936774

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Impact of the addition of concurrent chemotherapy to pelvic radiotherapy in surgically treated stage IB1-IIB cervical cancer patients with intermediate-risk or high-risk factors: a 13-year experience.
    Okazawa M, Mabuchi S, Isohashi F, Suzuki O, Yoshioka Y, Sasano T, Ohta Y, Kamiura S, Ogawa K, Kimura T.
    Int J Gynecol Cancer; 2013 Mar; 23(3):567-75. PubMed ID: 23385284
    [Abstract] [Full Text] [Related]

  • 3. Comparison of outcomes between early-stage cervical cancer patients without high-risk factors undergoing adjuvant concurrent chemoradiotherapy and radiotherapy alone after radical surgery.
    Zhou Y, Wang W, Tang J, Hu K, Zhang F.
    BMC Cancer; 2024 Apr 30; 24(1):548. PubMed ID: 38689248
    [Abstract] [Full Text] [Related]

  • 4. [Results of different postoperative adjuvant therapies for stage Ib-IIa cervical carcinoma with risk factors].
    Wen HW, Huang WP, Liu TY, Ma K, Tao X, Zhu LR, Liao QP.
    Zhonghua Fu Chan Ke Za Zhi; 2013 Dec 30; 48(12):920-4. PubMed ID: 24495686
    [Abstract] [Full Text] [Related]

  • 5. Adjuvant chemotherapy versus concurrent chemoradiotherapy for high-risk cervical cancer after radical hysterectomy and systematic lymphadenectomy.
    Takekuma M, Kasamatsu Y, Kado N, Kuji S, Tanaka A, Takahashi N, Abe M, Hirashima Y.
    Int J Clin Oncol; 2016 Aug 30; 21(4):741-747. PubMed ID: 26857458
    [Abstract] [Full Text] [Related]

  • 6. Comparison of salvage therapies for isolated para-aortic lymph node recurrence in patients with uterine cervical cancer after definitive treatment.
    Kubota H, Tsujino K, Sulaiman NS, Sekii S, Matsumoto Y, Ota Y, Soejima T, Yamaguchi S, Sasaki R.
    Radiat Oncol; 2019 Dec 26; 14(1):236. PubMed ID: 31878944
    [Abstract] [Full Text] [Related]

  • 7. Clinical behaviors and outcomes for adenocarcinoma or adenosquamous carcinoma of cervix treated by radical hysterectomy and adjuvant radiotherapy or chemoradiotherapy.
    Huang YT, Wang CC, Tsai CS, Lai CH, Chang TC, Chou HH, Lee SP, Hong JH.
    Int J Radiat Oncol Biol Phys; 2012 Oct 01; 84(2):420-7. PubMed ID: 22365621
    [Abstract] [Full Text] [Related]

  • 8. [Outcomes and prognostic factors of advanced squamous cervical cancer after concurrent chemoradiotherapy].
    Binbin T, Lingying W, Manni H, Jusheng A, Ning L.
    Zhonghua Fu Chan Ke Za Zhi; 2014 May 01; 49(5):348-54. PubMed ID: 25030731
    [Abstract] [Full Text] [Related]

  • 9. Adjuvant therapy after radical surgery for stage IB-IIB cervical adenocarcinoma with risk factors.
    Seki T, Tanabe H, Nagata C, Suzuki J, Suzuki K, Takano H, Isonishi S, Ochiai K, Takakura S, Okamoto A.
    Jpn J Clin Oncol; 2017 Jan 01; 47(1):32-38. PubMed ID: 27677664
    [Abstract] [Full Text] [Related]

  • 10. [Prognostic analysis of stage Ⅰb2 andⅡa2 cervical squamous cancer without high risk factors treated with neo-adjuvant chemotherapy and radical hysterectomy].
    Li PP, Li B, Wang YT, Liu SH, Zhang YN, Zhang R, Bai P, Li XG, Wu LY.
    Zhonghua Fu Chan Ke Za Zhi; 2018 Apr 25; 53(4):248-256. PubMed ID: 29747270
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Concurrent chemoradiotherapy with nedaplatin after radical hysterectomy in patients with stage IB and II cervical cancer.
    Kobayashi Y, Ohara T, Wada Y, Okuda Y, Kondo H, Okuma Y, Suzuki N, Gomi H, Kiguchi K, Ishizuka B.
    J Obstet Gynaecol Res; 2009 Jun 25; 35(3):490-4. PubMed ID: 19527388
    [Abstract] [Full Text] [Related]

  • 13. The long-term efficacy of neoadjuvant chemotherapy followed by radical hysterectomy compared with radical surgery alone or concurrent chemoradiotherapy on locally advanced-stage cervical cancer.
    Yin M, Zhao F, Lou G, Zhang H, Sun M, Li C, Hou Y, Li X, Meng F, Chen X.
    Int J Gynecol Cancer; 2011 Jan 25; 21(1):92-9. PubMed ID: 21330834
    [Abstract] [Full Text] [Related]

  • 14. Pathological Risk Factors and Outcomes in Women With Stage IB2 Cervical Cancer Treated With Primary Radical Surgery Versus Chemoradiotherapy.
    Bradbury M, Founta C, Taylor W, Kucukmetin A, Naik R, Ang C.
    Int J Gynecol Cancer; 2015 Oct 25; 25(8):1476-83. PubMed ID: 26244756
    [Abstract] [Full Text] [Related]

  • 15. [Comparative analysis of neoadjuvant therapies in stage Ib2 and IIa2 cervical carcinoma].
    Hu JL, Wu LY, Li N, Li XG, Huang MN, Zhang R.
    Zhonghua Fu Chan Ke Za Zhi; 2012 Jun 25; 47(6):452-7. PubMed ID: 22932113
    [Abstract] [Full Text] [Related]

  • 16. Chemoradiotherapy followed by consolidation chemotherapy involving paclitaxel and carboplatin and in FIGO stage IIIB/IVA cervical cancer patients.
    Mabuchi S, Isohashi F, Okazawa M, Kitada F, Maruoka S, Ogawa K, Kimura T.
    J Gynecol Oncol; 2017 Jan 25; 28(1):e15. PubMed ID: 27958682
    [Abstract] [Full Text] [Related]

  • 17. Postoperative concurrent nedaplatin-based chemoradiotherapy improves survival in early-stage cervical cancer patients with adverse risk factors.
    Mabuchi S, Morishige K, Isohashi F, Yoshioka Y, Takeda T, Yamamoto T, Yoshino K, Enomoto T, Inoue T, Kimura T.
    Gynecol Oncol; 2009 Dec 25; 115(3):482-7. PubMed ID: 19783286
    [Abstract] [Full Text] [Related]

  • 18. Postoperative concurrent chemoradiotherapy for the high-risk uterine cervical cancer.
    Takeshita S, Kita T, Motoike Y, Umezawa K, Sugisaki S, Matsumoto S, Matsumoto Y, Ryo E, Ayabe T.
    J Obstet Gynaecol Res; 2010 Oct 25; 36(5):1009-14. PubMed ID: 20722988
    [Abstract] [Full Text] [Related]

  • 19. [Outcomes and prognostic factors of distant metastasis in patients with advanced cervical squamous cell carcinoma treated with concurrent chemoradiotherapy].
    Ma R, Zhang H, Zou L, Qu Y.
    Zhonghua Fu Chan Ke Za Zhi; 2015 Feb 25; 50(2):125-30. PubMed ID: 25877610
    [Abstract] [Full Text] [Related]

  • 20. The prognostic value of histologic subtype in node-positive early-stage cervical cancer after hysterectomy and adjuvant radiotherapy.
    Zhou J, Zhang WW, Wu SG, He ZY, Sun JY, Yang GF, Li FY.
    Int J Surg; 2017 Aug 25; 44():1-6. PubMed ID: 28583891
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.